KEN vs. NVS
KEN (Kenon Holdings Ltd.) and NVS (Novartis AG) are both stocks. KEN operates in Utilities - Regulated Electric (Utilities), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, KEN returned 41.88%/yr vs 11.14%/yr for NVS. At a 0.13 correlation, their price movements are largely independent.
Performance
KEN vs. NVS - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with KEN having a 14.26% return and NVS slightly higher at 14.40%. Over the past 10 years, KEN has outperformed NVS with an annualized return of 41.88%, while NVS has yielded a comparatively lower 11.14% annualized return.
KEN
- 1D
- 0.54%
- 1M
- -20.01%
- YTD
- 14.26%
- 6M
- 23.62%
- 1Y
- 115.93%
- 3Y*
- 57.99%
- 5Y*
- 31.84%
- 10Y*
- 41.88%
NVS
- 1D
- -0.55%
- 1M
- 2.22%
- YTD
- 14.40%
- 6M
- 18.98%
- 1Y
- 30.60%
- 3Y*
- 19.57%
- 5Y*
- 14.77%
- 10Y*
- 11.14%
KEN vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KEN Kenon Holdings Ltd. | 14.26% | 126.18% | 62.44% | -19.16% | -23.73% | 93.65% | 57.17% | 50.73% | 23.06% | 85.88% |
NVS Novartis AG | 14.40% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
Correlation
The correlation between KEN and NVS is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jan 14, 2015 | 0.13 |
Fundamentals
KEN:
$3.84B
NVS:
$293.28B
KEN:
$1.54
NVS:
$6.99
KEN:
46.98
NVS:
21.90
KEN:
7.89
NVS:
1.48
KEN:
3.80
NVS:
5.29
KEN:
2.56
NVS:
7.62
KEN:
$1.01B
NVS:
$56.05B
KEN:
$166.82M
NVS:
$42.19B
KEN:
$339.95M
NVS:
$22.40B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KEN vs. NVS — Risk / Return Rank
KEN
NVS
KEN vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kenon Holdings Ltd. (KEN) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KEN | NVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.49 | ||
| Sortino ratioReturn per unit of downside risk | +1.24 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 1.26 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 4.42 | 2.43 | +1.98 |
| Martin ratioReturn relative to average drawdown | 17.27 | 5.88 | +11.39 |
Loading charts...
Drawdowns
KEN vs. NVS - Drawdown Comparison
The maximum KEN drawdown since its inception was -69.20%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for KEN and NVS.
Loading charts...
Drawdown Indicators
| KEN | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.20% | -42.10% | -27.10% |
Max Drawdown (1Y)Largest decline over 1 year | -26.41% | -12.65% | -13.76% |
Max Drawdown (3Y)Largest decline over 3 years | -32.27% | -19.95% | -12.32% |
Max Drawdown (5Y)Largest decline over 5 years | -69.20% | -20.42% | -48.78% |
Max Drawdown (10Y)Largest decline over 10 years | -69.20% | -26.03% | -43.17% |
Current DrawdownCurrent decline from peak | -24.16% | -6.46% | -17.70% |
Average DrawdownAverage peak-to-trough decline | -23.19% | -10.92% | -12.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.74% | 5.23% | +1.51% |
Volatility
KEN vs. NVS - Volatility Comparison
Kenon Holdings Ltd. (KEN) has a higher volatility of 14.84% compared to Novartis AG (NVS) at 7.18%. This indicates that KEN's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KEN | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.84% | 7.18% | +7.66% |
Volatility (6M)Calculated over the trailing 6-month period | 30.71% | 14.96% | +15.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.55% | 21.02% | +18.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.79% | 18.89% | +20.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.93% | 19.64% | +22.29% |
Dividends
KEN vs. NVS - Dividend Comparison
KEN's dividend yield for the trailing twelve months is around 5.31%, more than NVS's 3.12% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KEN Kenon Holdings Ltd. | 5.31% | 7.24% | 11.18% | 11.46% | 25.00% | 7.35% | 7.41% | 5.75% | 96.34% | 0.00% | 0.00% | 45.52% |
NVS Novartis AG | 3.12% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Financials
KEN vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Kenon Holdings Ltd. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KEN vs. NVS - Profitability Comparison
KEN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kenon Holdings Ltd. reported a gross profit of 47.00M and revenue of 317.00M. Therefore, the gross margin over that period was 14.8%.
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.
KEN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kenon Holdings Ltd. reported an operating income of 4.00M and revenue of 317.00M, resulting in an operating margin of 1.3%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.
KEN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kenon Holdings Ltd. reported a net income of 26.00M and revenue of 317.00M, resulting in a net margin of 8.2%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.
Frequently Asked Questions
KEN and NVS have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KEN has higher volatility (14.84%) compared to NVS (7.18%). In terms of maximum drawdown, KEN dropped -69.20% vs NVS's -42.10%.
KEN currently has the higher Sharpe Ratio (2.96 vs 1.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KEN and NVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer